CD4 and acute myeloid leukemia: The results demonstrated that high-risk AML patients had significantly high fractions in dendritic cell, memory CD4+, CD8+ T cell, immature B cells, macrophages, MDSC, monocyte, NK cells, and regulatory T cells compared with low-risk ones.